SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-23-039104
Filing Date
2023-11-02
Accepted
2023-11-02 12:57:41
Documents
84
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form6-k.htm   iXBRL 6-K 27062
2 ex99-1.htm   iXBRL EX-99.1 814636
3 ex99-2.htm EX-99.2 253180
  Complete submission text file 0001493152-23-039104.txt   6142625

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE tcbp-20230630.xsd EX-101.SCH 67080
5 XBRL CALCULATION FILE tcbp-20230630_cal.xml EX-101.CAL 65481
6 XBRL DEFINITION FILE tcbp-20230630_def.xml EX-101.DEF 193879
7 XBRL LABEL FILE tcbp-20230630_lab.xml EX-101.LAB 422890
8 XBRL PRESENTATION FILE tcbp-20230630_pre.xml EX-101.PRE 348494
78 EXTRACTED XBRL INSTANCE DOCUMENT form6-k_htm.xml XML 1037404
Mailing Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR
Business Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR 01414337557
TC BioPharm (Holdings) plc (Filer) CIK: 0001872812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41231 | Film No.: 231371098
SIC: 2836 Biological Products, (No Diagnostic Substances)